ArticleHemaSphere2022

Improved Clinical Outcome of COVID-19 in Hematologic Malignancy Patients Receiving a Fourth Dose of Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report.

Jon Salmanton-García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.